Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

MS-RADAM MultiScale phenomena in Radiation Damage

Coordinator
Mbn Research Center Ggmbh, Germany
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€4.4m
Total cost
—
Partners
22 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101225527

What the project is doing

In the project's own words, from its summary on CORDIS.

The MS-RADAM DN will deliver a state-of-the-art research programme that will pioneer a new approach to reveal key nano- and larger-scale radiation biodamage phenomena based on multiscale modelling (MM) and its thorough validation using advanced experimental techniques and technological applications. In particular, the MS-RADAM research programme will focus on obtaining an advanced understanding of Radiation Damage (RADAM) phenomena induced by ion irradiation in biomolecular and biological systems relevant to the application of this knowledge in particle therapy and many other relevant areas of research and technology.

The unique feature of the MS-RADAM research programme is the MM description and measurement of key processes and phenomena occurring on different temporal and spatial scales during ion-beam irradiation incorporating: (i) propagation of charged particles in biological media, (ii) radiation-induced fast quantum processes within biomolecular environments, (iii) characterisation of the time and spatial evolution of track structures and localised energy deposition, (iv) slower nanoscale post-irradiation relaxation, chemical and thermalisation processes occurring in the irradiated biological media, (v) evaluation of biodamage accounting for specific radiobiological effects.

To initiate such a programme and to provide industry, radiotherapy research community and many other related communities with a cohort of skilled researchers, MS-RADAM DN will train 14 Doctoral Candidates (DCs) in the methodology and skills needed for this emerging area of research and technology. MS-RADAM DN contains leading academic and industrial partners with the necessary experience to provide the international, interdisciplinary and intersectoral training needed for the MS-RADAM research programme, whist also providing the DCs a unique opportunity to gain comprehensive training in the complementary and entrepreneurial skills for their further career development.

Topics

Who is involved

OrganisationCityCountryRole
Mbn Research Center GgmbhGlashuettenGermanyCoordinator
Biofyzikalni Ustav Akademie Ved Ceske RepublikyBrnoCzechiaParticipant
Heyrovskeho ustav AV CR, v. v. i.PrahaCzechiaParticipant
Masarykova univerzitaBrnoCzechiaAssociatedpartner
Vysoka Skola Chemicko-Technologicka V PrazePrahaCzechiaAssociatedpartner
Carl Von Ossietzky Universitaet OldenburgOldenburgGermanyParticipant
FIZ Frankfurter Innovationszentrum Biotechnologie GmbHFrankfurt Am MainGermanyAssociatedpartner
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainFrankfurt Am MainGermanyAssociatedpartner
Ruprecht-Karls-Universitaet HeidelbergHeidelbergGermanyAssociatedpartner
PerpeVit ApsOdense MDenmarkAssociatedpartner
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceAssociatedpartner
Universite Paris-SaclayGif-Sur-YvetteFranceAssociatedpartner
Kutaisi International UniversityKutaisiGeorgiaAssociatedpartner
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Rijksuniversiteit GroningenGroningenNetherlandsParticipant
Raysearch Laboratories AB (publ)StockholmSwedenAssociatedpartner
Minerva Health & Care Communications LtdAndover HampshireUnited KingdomAssociatedpartner
Npl Management LimitedMiddlesexUnited KingdomAssociatedpartner
The Queen's University of BelfastBelfastUnited KingdomParticipant
University College LondonLondonUnited KingdomParticipant
University of KentCanterbury, KentUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI